000			03621nam a22003495i 4500
001			80106
003			ES-MaUEC
005			20230207040253.0
007			cr nn 008mamaa
008			140428s2014 xxk| s |||| 0|eng d
020			_a9781447163503
024	7		_a10.1007/978-1-4471-6350-3 _2doi
050		4	_aRC685.V2 _bM654 2014
245	1	0	_aMolecular Biology of Valvular Heart Disease _cedited by Nalini M. Rajamannan.
260			_aLondon _bSpringer _c2014
300			_a1 recurso en línea (XVII, 150 páginas) _b60 ilustraciones, 50 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aCalcific Aortic Valve Disease: The Role of the Stem Cell Niche -- In vitro Cell Culture Model of Calcification: Molecular Regulation of Myofibroblast Differentiation to an Osteoblast Phenotype -- Aortic Valve Apoptosis, Cell Proliferation and Atherosclerosis in Experimental Hypercholesterolemia -- Experimental Model of Aortic Valve Calcification to Induce Osteoblast Differentiation -- Development of an Experimental Model of Mitral Valve Regurgitation via Hypertrophic Chondrocytes -- Testing Drug Eluting Paclitaxel Balloon Valvuloplasty in an Experimental Model of Aortic Stenosis -- Ex vivo model for Bioprosthetic Valve Calcification via Stem Cell Differentiation -- Experimental Hypercholesterolemia in Genetic ApoE-/-/Lrp5-/- Mice: Proof of Principle -- Wnt3a-Lrp5 mediated Bicuspid Aortic Valve Disease -- Mouse Models of Calcific Aortic Valve Disease -- Hemodynamic Mechanisms of Bicuspid Aortic Valve Calcification and Aortopathy -- Bioreactor and biomaterial platforms for investigation of mitral valve biomechanics and mechanobiology -- Identification of early pathological events in calcific aortic valve disease by molecular imaging -- Role of ectonucleotidases and purinergic receptors in calcific aortic valve disease -- In vitro model of Drug Testing -- Application of the LDL-Density-Pressure Theory: The Mitral Valve -- Application of The LDL-Density-Radius Theory: The Aortic Valve.
520	3		_aThis book presents the cellular details and the basic molecular biology approaches for understanding cardiac valvular disease. It provides novel cellular targets for developing future clinical trials and comprehensive clinical discussion of this expanding field. Molecular Biology of Valvular HeartÂ{u4A73}sease will guide physicians on the potential medical therapies to treat valvular heart disease while providing a platform for cellular targeting of valvular heart disease. Residents and fellows in cardiology, interventional cardiology, cardiac surgery, and current and future valve biologists alike will find this book to be an invaluable resource for developing further interest and understanding of the cellular basis for cardiac valvular disease treatment.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, asignarmaterias, EBSPRINGER,
650		7	_9138557 _aCardiología _2embne
650		7	_9138557 _aCardiología _2fast
700	1		_aRajamannan, Nalini M _eeditor literario _988012 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4471-6350-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12878595 _b10-10-17 _c11-11-15
998			_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _gxxk _h0
945			_aRC685.V2 M654 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11558416 _z06-04-17
999			_c80106 _d80106 _x1